BridgeBio Pharma, Inc.BBIONASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Performance
Trending lower, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-10.22%
↑ 17% above average
Average (7y)
-12.30%
Historical baseline
Range
High:-1.61%
Low:-37.89%
CAGR
+30.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -10.22% | -26.9% |
| 2023 | -8.05% | +78.8% |
| 2022 | -37.89% | -67.1% |
| 2021 | -22.68% | -367.4% |
| 2020 | -4.85% | +30.9% |
| 2019 | -7.02% | -15.4% |
| 2018 | -6.09% | -278.1% |
| 2017 | -1.61% | - |